_version_ 1784598780834742272
author Schetelig, Johannes
Hoek, Jennifer
Stilgenbauer, Stephan
Middeke, Jan Moritz
Andersen, Niels Smedegaard
Fox, Christopher P.
Lenhoff, Stig
Volin, Liisa
Shimoni, Avichai
Schroyens, Wilfried
van Gelder, Michel
Bunjes, Donald
van Biezen, Anja
Baldauf, Henning
de Wreede, Liesbeth C.
Tournilhac, Olivier
Kröger, Nicolaus
Yakoub-Agha, Ibrahim
Dreger, Peter
author_facet Schetelig, Johannes
Hoek, Jennifer
Stilgenbauer, Stephan
Middeke, Jan Moritz
Andersen, Niels Smedegaard
Fox, Christopher P.
Lenhoff, Stig
Volin, Liisa
Shimoni, Avichai
Schroyens, Wilfried
van Gelder, Michel
Bunjes, Donald
van Biezen, Anja
Baldauf, Henning
de Wreede, Liesbeth C.
Tournilhac, Olivier
Kröger, Nicolaus
Yakoub-Agha, Ibrahim
Dreger, Peter
author_sort Schetelig, Johannes
collection PubMed
description
format Online
Article
Text
id pubmed-8589674
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-85896742021-11-23 Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational study Schetelig, Johannes Hoek, Jennifer Stilgenbauer, Stephan Middeke, Jan Moritz Andersen, Niels Smedegaard Fox, Christopher P. Lenhoff, Stig Volin, Liisa Shimoni, Avichai Schroyens, Wilfried van Gelder, Michel Bunjes, Donald van Biezen, Anja Baldauf, Henning de Wreede, Liesbeth C. Tournilhac, Olivier Kröger, Nicolaus Yakoub-Agha, Ibrahim Dreger, Peter Bone Marrow Transplant Correspondence Nature Publishing Group UK 2020-08-16 2021 /pmc/articles/PMC8589674/ /pubmed/32801318 http://dx.doi.org/10.1038/s41409-020-01013-y Text en © The Author(s) 2020, corrected publication 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Schetelig, Johannes
Hoek, Jennifer
Stilgenbauer, Stephan
Middeke, Jan Moritz
Andersen, Niels Smedegaard
Fox, Christopher P.
Lenhoff, Stig
Volin, Liisa
Shimoni, Avichai
Schroyens, Wilfried
van Gelder, Michel
Bunjes, Donald
van Biezen, Anja
Baldauf, Henning
de Wreede, Liesbeth C.
Tournilhac, Olivier
Kröger, Nicolaus
Yakoub-Agha, Ibrahim
Dreger, Peter
Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational study
title Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational study
title_full Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational study
title_fullStr Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational study
title_full_unstemmed Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational study
title_short Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational study
title_sort allogeneic hematopoietic cell transplantation for patients with tp53 mutant or deleted chronic lymphocytic leukemia: results of a prospective observational study
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589674/
https://www.ncbi.nlm.nih.gov/pubmed/32801318
http://dx.doi.org/10.1038/s41409-020-01013-y
work_keys_str_mv AT scheteligjohannes allogeneichematopoieticcelltransplantationforpatientswithtp53mutantordeletedchroniclymphocyticleukemiaresultsofaprospectiveobservationalstudy
AT hoekjennifer allogeneichematopoieticcelltransplantationforpatientswithtp53mutantordeletedchroniclymphocyticleukemiaresultsofaprospectiveobservationalstudy
AT stilgenbauerstephan allogeneichematopoieticcelltransplantationforpatientswithtp53mutantordeletedchroniclymphocyticleukemiaresultsofaprospectiveobservationalstudy
AT middekejanmoritz allogeneichematopoieticcelltransplantationforpatientswithtp53mutantordeletedchroniclymphocyticleukemiaresultsofaprospectiveobservationalstudy
AT andersennielssmedegaard allogeneichematopoieticcelltransplantationforpatientswithtp53mutantordeletedchroniclymphocyticleukemiaresultsofaprospectiveobservationalstudy
AT foxchristopherp allogeneichematopoieticcelltransplantationforpatientswithtp53mutantordeletedchroniclymphocyticleukemiaresultsofaprospectiveobservationalstudy
AT lenhoffstig allogeneichematopoieticcelltransplantationforpatientswithtp53mutantordeletedchroniclymphocyticleukemiaresultsofaprospectiveobservationalstudy
AT volinliisa allogeneichematopoieticcelltransplantationforpatientswithtp53mutantordeletedchroniclymphocyticleukemiaresultsofaprospectiveobservationalstudy
AT shimoniavichai allogeneichematopoieticcelltransplantationforpatientswithtp53mutantordeletedchroniclymphocyticleukemiaresultsofaprospectiveobservationalstudy
AT schroyenswilfried allogeneichematopoieticcelltransplantationforpatientswithtp53mutantordeletedchroniclymphocyticleukemiaresultsofaprospectiveobservationalstudy
AT vangeldermichel allogeneichematopoieticcelltransplantationforpatientswithtp53mutantordeletedchroniclymphocyticleukemiaresultsofaprospectiveobservationalstudy
AT bunjesdonald allogeneichematopoieticcelltransplantationforpatientswithtp53mutantordeletedchroniclymphocyticleukemiaresultsofaprospectiveobservationalstudy
AT vanbiezenanja allogeneichematopoieticcelltransplantationforpatientswithtp53mutantordeletedchroniclymphocyticleukemiaresultsofaprospectiveobservationalstudy
AT baldaufhenning allogeneichematopoieticcelltransplantationforpatientswithtp53mutantordeletedchroniclymphocyticleukemiaresultsofaprospectiveobservationalstudy
AT dewreedeliesbethc allogeneichematopoieticcelltransplantationforpatientswithtp53mutantordeletedchroniclymphocyticleukemiaresultsofaprospectiveobservationalstudy
AT tournilhacolivier allogeneichematopoieticcelltransplantationforpatientswithtp53mutantordeletedchroniclymphocyticleukemiaresultsofaprospectiveobservationalstudy
AT krogernicolaus allogeneichematopoieticcelltransplantationforpatientswithtp53mutantordeletedchroniclymphocyticleukemiaresultsofaprospectiveobservationalstudy
AT yakoubaghaibrahim allogeneichematopoieticcelltransplantationforpatientswithtp53mutantordeletedchroniclymphocyticleukemiaresultsofaprospectiveobservationalstudy
AT dregerpeter allogeneichematopoieticcelltransplantationforpatientswithtp53mutantordeletedchroniclymphocyticleukemiaresultsofaprospectiveobservationalstudy